Company intelligence / Profile preview

Persist AI

West Sacramento, California, United Statespersist-ai.com ↗

Ownership: Private
Development stage: Commercial

Overview

Persist AI’s robotic/AI-driven platform reduces pharmaceutical formulation development time from years to months. Their technology allows remote design/testing of formulations via the Cloud Lab. The company has demonstrated 30–50% faster timelines compared to traditional methods and serves multiple top 10 pharma companies as well as biotechs developing next-generation therapeutics. No direct clinical results since they are a service/platform provider rather than a therapeutic developer themselves.

Therapeutic areas: OtherDermatology
Modalities: Peptidessmall moleculesantibodies (mAbs)anti-sense oligonucleotides
Industry: Drug Discovery Services

Partnerships

Nivagen Pharmaceuticals (GMP manufacturing system collaboration)Multiple top 10 pharmaceutical companies (clients)

Beyond the preview

Go deeper on Persist AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Persist AI.

Explore the full profile